Medicine recalls
|
| |
| Australia: Recall of Febridol paracetamol 500 mg (100 tablet bottles) - possible contamination |
| |
Consumers, health professionals and suppliers are advised that Ascent Pharmaceuticals and Cipla Australia, in consultation with the Therapeutic Goods Administration (TGA), are recalling one batch of Febridol Paracetamol 500 mg 100 tablet bottles. Febridol Paracetamol 500 mg contains paracetamol, which is used to treat aches, pains and feverish conditions. It has been found that one batch of Febridol Paracetamol 500 mg 100 tablet bottles (batch number ACN2134, expiry date August 2014), supplied in NSW and the ACT, may contain a foreign tablet that is peach (orange/pink) in colour and triangular in shape. It can be easily identified among Febridol Paracetamol 500 mg tablets, which are white and round. The manufacturer is undertaking an investigation to identify the peach-coloured tablet. Taking the peach-coloured tablet could be harmful. No other batches of Febridol Paracetamol 500 mg, either in 100 tablet bottles or 100 tablet blister packs, are affected by this recall. Consumers are advised to check the batch number, if they have any Febridol Paracetamol 500 mg 100 tablet bottles. If the batch number is ACN2134, with expiry date August 2014, do not take any medicine from that bottle and return the bottle to the place of purchase or return them to Ascent Pharmaceuticals.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/alerts-medicine-febridol-paracetamol-130724.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Thursday, July 25, 2013
Issued at HKT 16:00 |
| |
